Accelerating growth: the double-edged sword of self-reliance
With the world seeking an alternative for China, will India rise to the occasion and indeed be the 'pharmacy to the world'?
N Mahalakshmi - July 26, 2021
Can the country’s manufacturing push be sustained with ‘PLIS’ and thank you?
With the second wave of Covid-19 pushing the economy into another downward spiral, the burden is now on the PLI scheme to revive growth
N Mahalakshmi - June 04, 2021
PLIS: What’s it got
Here’s a measure of the scheme’s ambition, account of achievements so far, and a record of brickbats and bouquets
June 04, 2021
Driven by diligence
Canara Robeco's Cheenu Gupta believes in knowing her companies inside out, and never being too sure of one’s analysis
Anishaa Kumar - March 01, 2021
Prescription written in sloppy handwriting? This start-up offers an antidote
Equipping doctors with digital tools, Farmako aims to build India’s first centralised health record system
Shailaja Mohapatra - January 14, 2021
When the sun shines
Non-executive director Sudhir Valia sells Sun Pharma stock worth ₹2.91 billion held by Raksha Valia
Shailaja Mohapatra - January 16, 2021
Selling prescription drugs can be a pain. Doceree offers an easy way out
The pharma-marketing start-up has patented tech to reach the right message to the right doctor
Debangana Ghosh - November 04, 2020
Jingoism buried, IPO done, stock price up 50%. What next for Gland Pharma?
Its IPO was talk of the town, but investors gave it a miss. Now, the company is having the last laugh
V Keshavdev - December 10, 2020
“I do not take the market’s view as gospel truth, but I also do not assume it is foolish or stupid”
ASK Group’s Bharat Shah on why the market is his guidepost when it comes to deciphering tangible price and intangible value
N Mahalakshmi - October 17, 2020
Chronic profit
Eris Lifesciences promoter Himanshu Shah sells stock worth ₹968 million
Shailaja Mohapatra - October 08, 2020
